Close Menu

NEW YORK – Bruker said today it has completed debt financing with which it aims to add to its financial flexibility and fund corporate strategic objectives.

The company said the move takes advantage of low interest rates in the US and Europe while fixing rates on roughly 60 percent of its borrowing capacity and extending debt maturities to 2026 and 2029.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.